US Stock MarketDetailed Quotes

TVTX Travere Therapeutic

Watchlist
  • 5.720
  • -0.080-1.38%
Close Apr 19 16:00 ET
  • 5.750
  • +0.030+0.52%
Post 19:02 ET
435.34MMarket Cap-3813P/E (TTM)

About Travere Therapeutic Company

Travere Therapeutics, Inc. is a biopharmaceutical company. It engages in the identification, development, commercialization, and distribution of therapies to people living with rare diseases. The firm's products include Chenodal, Cholbam, and Thiola. The company was founded by Martin Shkreli on February 7, 2008 and is headquartered in San Diego, CA.

Company Profile

SymbolTVTX
Company NameTravere Therapeutic
Listing DateJan 10, 2014
Founded2008
CEODr. Eric M. Dube, PhD
MarketNASDAQ
Employees380
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address3611 Valley Centre Drive,Suite 300
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92130
Phone1-888-969-7879
Websitehttp://www.travere.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Eric M. Dube, PhD
  • Director, President and Chief Executive Officer
  • 7.57M
  • Peter Heerma
  • Chief Commercial Officer
  • 2.00M
  • Sandra Calvin
  • Senior Vice President and Chief Accounting Officer
  • --
  • Christopher Cline
  • Chief Financial Officer
  • 1.97M
  • Dr. Jula Inrig
  • Chief Medical Officer
  • --
  • William E. Rote
  • Senior Vice President, Research and Development
  • 2.05M
  • Elizabeth E. Reed
  • Senior Vice President, General Counsel and Corporate Secretary
  • 2.02M
  • Gary A. Lyons
  • Chairman of the Board
  • 392.98K
  • Timothy P. Coughlin
  • Independent Director
  • 385.48K
  • John A. Orwin
  • Independent Director
  • 372.98K
  • Jeffrey A. Meckler
  • Independent Director
  • 379.98K
  • Ron Squarer
  • Independent Director
  • 367.98K
  • Dr. Suzanne L. Bruhn, PhD
  • Independent Director
  • 372.36K
  • Sandra E. Poole
  • Independent Director
  • 369.86K
  • Dr. Roy D. Baynes, M.D.,PhD
  • Independent Director
  • 376.73K
  • Ruth WilliaBrinkley
  • Independent Director
  • 365.48K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg